You are here: Industry Insights > cancer

News List

Cancer treatment could be replicated for COVID-19 worldpharmanews
November 06, 2020
Beta-blockers could potentially be used to treat COVID-19, according to a new international study by Italian and Australian scientists.
Syntrix Completes Initial SX-682 Dosing in Cancer Trial Campaign americanpharmaceuticalreview
November 05, 2020
Syntrix Pharmaceuticals has completed initial SX-682 dosing in Phase 1/2 trials in myelodysplastic syndromes (MDS) and metastatic melanoma. The drug was well tolerated and absorbed with excellent dose-proportional drug levels in blood.
Fusion Pharma, AstraZeneca Enter Radiopharmaceuticals Alliance contractpharma
November 04, 2020
Leverages Fusion's Targeted Alpha Therapies platform and radiopharmaceuticals expertise and AstraZeneca's portfolio of antibodies and cancer therapies.
AVATAMED and Macrogen sign MOU on joint business in personalized precision medicine services in cancer treatment prnasia
October 30, 2020
AVATAMED, a precision medicine service company based in Singapore, represented by CEO Mr. Hong Boon Toh, has entered into a business agreement on 29 October 2020 with Macrogen, a biotechnology company in precision medicine headquartered in South Korea ...
Blood test more predictive of ovarian cancer than ‘previously thought’ pharmatimes
October 30, 2020
An already available blood test can better predict ovarian cancer than was previously thought, according to research published in PLOS Medicine yesterday.
New Study Finds COVID-19 Substantially Reduced Cancer Screenings, Diagnosis, and Treatments in 2020 prnewswire
October 22, 2020
Breast, colon, prostate, and lung cancers did not stop for COVID-19 in 2020, but screenings and treatments did. Dramatically. The result, say doctors, could be a catastrophe in the making.
Epsilogen awarded £1m grant from Innovate UK pharmatimes
October 22, 2020
London-based Epsilogen has been awarded a £1m grant from the UK’s innovation agency Innovate UK to further develop a novel immunoglobulin E (IgE) antibody to treat cancer.
Samsung Biologics partners with BioEleven for cancer immunotherapy development and manufacturing prnasia
October 21, 2020
Samsung Biologics has entered into a partnership agreement with BioEleven to develop and manufacture BN-101A, a third-generation immunotherapy to treat cancer.
Financial Report; Johnson & Johnson contractpharma
October 19, 2020
Pharmaceutical sales were up 5% in the quarter to $11.4 billion.
First Patient Dosed in Trial of LNS8801, KEYTRUDA Combination in Advanced Cancer americanpharmaceuticalreview
October 19, 2020
Linnaeus Therapeutics has dosed the first patient in its phase 1/2 adaptive-design clinical trial of its lead-product-candidate, LNS8801, in combination with KEYTRUDA® (pembrolizumab) in patients who had previous clinical benefit from immune checkpoint...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page